Min Chen Selected Research

rhoA GTP-Binding Protein

6/2016	Nucleolar localization of Small G protein RhoA is associated with active RNA synthesis in human carcinoma HEp-2 cells.
10/2013	Nuclear translocation of small G protein RhoA via active transportation in gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Chen Research Topics

Disease

245	Neoplasms (Cancer) 09/2022 - 01/2002
87	Infections 11/2022 - 12/2003
67	Inflammation (Inflammations) 09/2022 - 03/2004
65	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 02/2007
55	Breast Neoplasms (Breast Cancer) 09/2022 - 06/2005
51	Vasculitis (Vasculitides) 01/2022 - 11/2005
39	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2002
33	Stomach Neoplasms (Stomach Cancer) 05/2022 - 09/2011
31	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2005
28	Carcinogenesis 01/2022 - 02/2010
27	Insulin Resistance 10/2022 - 07/2004
27	Glomerulonephritis 01/2021 - 02/2007
23	Fibrosis (Cirrhosis) 12/2022 - 01/2007
23	Hypoxia (Hypoxemia) 09/2022 - 09/2014
22	Body Weight (Weight, Body) 01/2022 - 06/2002
19	Wounds and Injuries (Trauma) 06/2022 - 06/2003
19	Obesity 11/2021 - 07/2004
18	Chronic Hepatitis B 10/2022 - 04/2003
18	Hemorrhage 01/2021 - 06/2009
17	COVID-19 09/2022 - 01/2020
17	Ischemia 05/2022 - 08/2002
17	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 02/2010
17	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2002
16	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2011
16	Hypertension (High Blood Pressure) 12/2021 - 01/2004
16	Parkinson Disease (Parkinson's Disease) 11/2021 - 08/2007
16	Type 2 Diabetes Mellitus (MODY) 09/2021 - 11/2009
15	Carcinoma (Carcinomatosis) 04/2022 - 01/2009
15	Stroke (Strokes) 12/2021 - 04/2006
15	Lung Neoplasms (Lung Cancer) 10/2021 - 09/2008
14	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 12/2007
14	Leukemia 01/2022 - 04/2013
14	Asthma (Bronchial Asthma) 01/2021 - 10/2004
14	Microscopic Polyangiitis 01/2019 - 01/2007
13	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2014
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2010
13	Proteinuria 08/2021 - 02/2007
13	Sepsis (Septicemia) 01/2021 - 04/2006
12	Adenocarcinoma 01/2022 - 09/2009
12	Necrosis 06/2021 - 03/2007
12	Crohn Disease (Crohn's Disease) 01/2021 - 03/2007
12	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 06/2009
12	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2004
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 03/2011
11	Pneumonia (Pneumonitis) 01/2022 - 04/2012
11	Schizophrenia (Dementia Praecox) 01/2022 - 12/2012
11	Migraine Disorders (Migraine) 11/2021 - 01/2015
11	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2007
11	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2010
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2007
10	Reperfusion Injury 05/2022 - 08/2002
10	Spinal Cord Injuries (Spinal Cord Injury) 04/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

109	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2002
86	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 11/2002
63	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2007
55	Pharmaceutical PreparationsIBA 02/2022 - 01/2002
44	CytokinesIBA 10/2022 - 01/2005
38	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2002
34	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 11/2005
33	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2011
33	AntibodiesIBA 01/2022 - 01/2005
32	Messenger RNA (mRNA)IBA 03/2022 - 01/2002
32	AutoantibodiesIBA 01/2022 - 11/2002
25	CreatinineIBA 01/2022 - 01/2007
25	Peroxidase (Myeloperoxidase)IBA 09/2021 - 11/2005
24	Biological ProductsIBA 05/2022 - 10/2015
23	LipidsIBA 04/2022 - 10/2002
22	VaccinesIBA 01/2022 - 04/2003
22	Peptides (Polypeptides)IBA 01/2022 - 08/2002
22	EnzymesIBA 12/2021 - 03/2004
22	AntigensIBA 10/2021 - 11/2002
21	Therapeutic UsesIBA 11/2021 - 12/2002
19	Complement System Proteins (Complement)IBA 01/2021 - 01/2005
16	Immunoglobulin G (IgG)IBA 01/2022 - 12/2003
15	Interleukin-6 (Interleukin 6)IBA 09/2022 - 06/2007
15	IronIBA 05/2022 - 02/2008
15	Insulin (Novolin)FDA Link 01/2022 - 01/2002
15	Tyrosine Kinase InhibitorsIBA 01/2021 - 07/2012
14	Indicators and Reagents (Reagents)IBA 12/2022 - 01/2014
14	Protons (Proton)IBA 11/2022 - 09/2009
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 02/2006
14	Phosphotransferases (Kinase)IBA 01/2021 - 05/2004
13	Interleukin-17 (Interleukin 17)IBA 10/2022 - 01/2014
13	Transcription Factors (Transcription Factor)IBA 07/2022 - 06/2005
13	Long Noncoding RNAIBA 05/2022 - 10/2017
13	Hormones (Hormone)IBA 01/2021 - 06/2002
12	HMGB1 Protein (HMG1)IBA 10/2022 - 01/2015
12	C-Reactive ProteinIBA 09/2022 - 04/2006
11	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2013
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2013
11	AmidesIBA 01/2022 - 02/2013
11	Matrix Metalloproteinases (MMPs)IBA 06/2021 - 11/2006
11	Anti-Bacterial Agents (Antibiotics)IBA 06/2020 - 08/2009
10	Oxygen (Dioxygen)IBA 09/2022 - 01/2004
10	CollagenIBA 05/2022 - 03/2005

Therapy/Procedure

162	Therapeutics 12/2022 - 01/2002
36	Drug Therapy (Chemotherapy) 01/2022 - 02/2012
14	Radiotherapy 01/2022 - 01/2014
13	Immunotherapy 05/2022 - 05/2003
12	Aftercare (After-Treatment) 01/2022 - 10/2006